FDA
- Status: approved
Initiating daily oral PrEP during pregnancy (Initiating daily oral PrEP during pregnancy) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
University of North Carolina, Chapel Hill is the originator. The local marketing authorisation holder may differ — check the official source linked above.